Camila Simões

Assistant Professor

UAMS

Also affiliated: Mount Sinai Hospital (2020); The University of Texas MD Anderson Cancer Center (2019); University of Arkansas Medical Center (2022–2024); Yale University (2011); The University of Texas Medical Branch at Galveston (2011–2019); University of Cincinnati (2011); Icahn School of Medicine at Mount Sinai (2020–2024)

Pathology, College of Medicine

7 h-index 42 pubs 141 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Camila Simões, Assistant Professor in Pathology at the University of Arkansas for Medical Sciences, investigates mechanisms of disease and potential therapeutic strategies. Her research has explored the efficacy of dietary interventions and novel virotherapy platforms for liver cancers. Recent work includes characterizing Morreton virus as an oncolytic agent for liver cancers and examining the morphological changes in hepatocellular carcinoma following immune checkpoint inhibitor therapy.

Simões's publications also address broader public health concerns, including the dissemination of SARS-CoV-2 and the treatment of Hepatitis C. She has a collaborative network with several researchers at the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications. Her scholarship metrics include an h-index of 7 with 147 total citations across 48 publications.

Metrics

h-index: 7
Publications: 42
Citations: 141

Positions

Assistant Professor publications 2022–2026

University of Arkansas for Medical Sciences Pathology, College of Medicine Institutional directory

Selected Publications

Abstract 4378: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models (2026)

Cancer Research DOI OpenAlex
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response (2026)

Journal for ImmunoTherapy of Cancer DOI OpenAlex
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025)

Frontiers in Immunology 1 citation DOI OpenAlex
Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models (2025)

Cancer Research DOI OpenAlex
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade (2024)

Molecular Therapy Oncology 5 citations DOI OpenAlex
S3275 A Case of “Black Esophagus” Following Esophageal Candidiasis (2024)

The American Journal of Gastroenterology DOI OpenAlex
S5193 More Than Just a Variceal Bleed: Multiple Portal Hypertensive Gastric Polyps in a Case of Advanced Cirrhosis (2024)

The American Journal of Gastroenterology DOI OpenAlex
Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson Disease (2024)

Modern Pathology 7 citations DOI OpenAlex
Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer (2024)

Biomedicines 6 citations DOI OpenAlex
Abstract 588: Preclinical evaluation of novel chimeric vesiculovirus mediated expression of proteolytic enzymes targeting two major stromal components of pancreatic ductal adenocarcinoma (2024)

Cancer Research DOI OpenAlex
Abstract 5004: Oncolytic Jurona-driven systemic and intratumoral immunotherapy combined with immune checkpoint blockade boost immune response and survival in hepatocellular carcinoma models (2024)

Cancer Research DOI OpenAlex
Increased Response to Immune Checkpoint Inhibitors with Dietary Methionine Restriction in a Colorectal Cancer Model (2023)

Cancers 31 citations DOI OpenAlex
S3266 A Comparison of Two Cases of Acute Graft versus Host Disease Following Liver Transplant (2022)

The American Journal of Gastroenterology 1 citation DOI OpenAlex
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy (2022)

Frontiers in Oncology 7 citations DOI OpenAlex
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers (2022)

Hepatology 14 citations DOI OpenAlex